Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01058_DB06414_nanopub.RAM7rMTc-rjCiUOywvmc7yQVBUj7SPorVmIB47TgX4FK0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01058_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01058_DB06414 label "DDI between Praziquantel and Etravirine - Praziquantel, when used concomitantly with etravirine (a strong CYP3A4 inducer), may experience a decrease in serum concentration. It is recommended to avoid concurrent therapy. [drugbank_resource:DB01058_DB06414]" assertion.
- drugbank_resource:DB01058_DB06414 identifier "drugbank_resource:DB01058_DB06414" assertion.
- drugbank_resource:DB01058_DB06414 title "DDI between Praziquantel and Etravirine - Praziquantel, when used concomitantly with etravirine (a strong CYP3A4 inducer), may experience a decrease in serum concentration. It is recommended to avoid concurrent therapy." assertion.
- drugbank:DB06414 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01058_DB06414 assertion.
- drugbank:DB01058 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01058_DB06414 assertion.